Company / Capital Expenditures
CG Oncology, Inc. Capital Expenditures History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$134.0K
FY2025
5-year range
$134.0K / $234.0K
FY2024-FY2025
Trend
-42.7%
vs FY2024
Sector context
#168 of 195
Health Care
What the data says
CG Oncology, Inc.'s capital expenditures of $134,000 is lower than 86% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$134,000 in FY2025.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 195This company $134.0K Sector average $116.9M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capital expenditures decreased 42.7% year-over-year.
- Ranks #168 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $134.0K | -42.7% |
| FY2024 | $234.0K | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026